Comparative Pharmacology
Head-to-head clinical analysis: MOXIDECTIN versus NATROBA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: MOXIDECTIN versus NATROBA.
MOXIDECTIN vs NATROBA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Moxidectin is a macrocyclic lactone that binds to glutamate-gated chloride ion channels in invertebrate nerve and muscle cells, leading to increased chloride ion influx, hyperpolarization, and paralysis/death of susceptible parasites. It also potentiates gamma-aminobutyric acid (GABA)-gated chloride channels.
Natroba is a pediculicide that inhibits neuronal depolarization by binding to and blocking voltage-gated sodium channels in the nervous system of lice, leading to paralysis and death of the parasite.
Oral: 8 mg once daily for 1-2 days for onchocerciasis; 8 mg once for strongyloidiasis.
Apply a single, 10-minute application of the lotion (0.5% w/w ivermectin) to dry hair and scalp in an amount sufficient to thoroughly coat the hair and scalp (up to 1 tube for adults); rinse off with water after 10 minutes.
None Documented
None Documented
Terminal elimination half-life is approximately 11–12 days in healthy adults; prolonged to 20–30 days in patients with hepatic impairment due to reduced clearance.
Terminal elimination half-life is approximately 10–12 hours in patients with normal hepatic function; prolonged in severe hepatic impairment.
Primarily fecal (≈75% of total clearance) via biliary excretion of unchanged drug and metabolites; renal excretion accounts for <1% of the dose.
Primarily fecal (approximately 90% of absorbed dose) with minor renal elimination (<10% as unchanged drug).
Category C
Category C
Antiparasitic
Antiparasitic, Topical